Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

1.7K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.7K
Overview of Metabolism01:40

Overview of Metabolism

25.7K
Living cells constantly carry out various chemical reactions which are necessary for their proper functioning. These reactions are interlinked to one another via multiple pathways. The collection of these chemical reactions is known as metabolism.
Plant Metabolism
Sunlight, the primary source of energy in plants, is first absorbed by the chlorophyll pigments present in their leaves. Plants then use this energy to carry out photosynthesis, where water is oxidized into oxygen and carbon dioxide...
25.7K
Epilepsy ll: Types01:22

Epilepsy ll: Types

47
Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
47
Seizures l: Introduction01:20

Seizures l: Introduction

42
Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
42
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

1.7K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.7K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

1.2K
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antiseizure Medications Impact Mitochondrial Ion Channels via Novel Bioenergetic and Neural Mechanisms.

Journal of integrative neuroscience·2026
Same author

Dysregulation of the Extracellular Matrix in the Synaptic Pathology of Parkinson's Disease: Molecular Mechanisms and Novel Therapeutic Approaches.

Life (Basel, Switzerland)·2026
Same author

Correction: Rubio et al. Classification of Current Experimental Models of Epilepsy. <i>Brain Sci.</i> 2024, <i>14</i>, 1024.

Brain sciences·2026
Same author

Machine learning in epilepsy.

Epilepsy research·2026
Same author

Opioid Receptors in Psychedelia: Indirect Serotonergic Modulation of Direct KOR Activation by Salvinorin A.

Biomedicines·2026
Same author

The Extracellular Matrix, the Silent 'Architect' of Glioma.

Biomedicines·2026

Related Experiment Video

Updated: May 5, 2026

Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients
09:32

Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients

Published on: December 18, 2016

13.7K

The Hidden Metabolic Roots of Epilepsy.

Carmen Rubio1, Sergio Carpinteyro2, Norma Serrano-García1

  • 1Department of Neurophysiology, National Institute of Neurology and Neurosurgery, Mexico City 14269, Mexico.

Biomedicines
|May 4, 2026
PubMed
Summary
This summary is machine-generated.

Epilepsy is increasingly viewed as a neuro-metabolic disorder, linked bidirectionally with obesity and metabolic syndrome (MetS). This connection involves shared pathways affecting inflammation, insulin resistance, and gut-brain axis signaling.

Keywords:
epilepsygut-brain axisinsulin resistancemetabolic syndromemitochondrial dysfunctionneuroinflammation

More Related Videos

Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats
08:47

Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats

Published on: November 8, 2018

11.2K
Recording and Modulation of Epileptiform Activity in Rodent Brain Slices Coupled to Microelectrode Arrays
10:24

Recording and Modulation of Epileptiform Activity in Rodent Brain Slices Coupled to Microelectrode Arrays

Published on: May 15, 2018

16.6K

Related Experiment Videos

Last Updated: May 5, 2026

Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients
09:32

Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients

Published on: December 18, 2016

13.7K
Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats
08:47

Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats

Published on: November 8, 2018

11.2K
Recording and Modulation of Epileptiform Activity in Rodent Brain Slices Coupled to Microelectrode Arrays
10:24

Recording and Modulation of Epileptiform Activity in Rodent Brain Slices Coupled to Microelectrode Arrays

Published on: May 15, 2018

16.6K

Area of Science:

  • Neurobiology
  • Metabolic Syndrome Research
  • Epilepsy Pathophysiology

Background:

  • Epilepsy is recognized as a systemic condition with metabolic dysregulation, not just neuronal hyperexcitability.
  • A bidirectional relationship exists between epilepsy, obesity, and metabolic syndrome (MetS).
  • Shared molecular pathways link seizures, antiseizure medications (ASM), and neuroinflammation to epileptogenesis.

Purpose of the Study:

  • To synthesize the complex interplay between epilepsy, obesity, and MetS.
  • To propose a reconceptualization of epilepsy as a neuro-metabolic disorder.
  • To identify novel therapeutic targets addressing both seizure control and metabolic regulation.

Main Methods:

  • Review of cellular and molecular mechanisms connecting epilepsy, obesity, and MetS.
  • Analysis of the role of oxidative stress, mitochondrial dysfunction, and neuroinflammation.
  • Examination of the gut-brain axis and its influence on metabolic and neurological function.

Main Results:

  • Chronic epileptic activity and ASM can induce metabolic dysregulation, including insulin resistance and weight gain.
  • Obesity and MetS promote neuroinflammation and excitotoxicity, increasing seizure susceptibility.
  • The gut-brain axis, dysbiosis, and altered metabolites significantly contribute to this neuro-metabolic link.

Conclusions:

  • Epilepsy, obesity, and MetS are interconnected through shared neuro-inflammatory and metabolic pathways.
  • Reconceptualizing epilepsy as a neuro-metabolic disorder opens avenues for integrated treatment strategies.
  • Therapeutic approaches targeting microbiota, inflammation, and insulin sensitivity hold promise for managing epilepsy and metabolic dysfunction.